Derek Raghavan, MD, PhD, credits his mentors, including John Sands, MD, and Munro Neville, MD, PhD, for much of his career success. The former was a major influence during his residency at the University of Sydney, whereas the latter was his PhD supervisor at the University of London. Raghavan came on board to help create an innovative Mesa will assume the roles filled by Dr. Derek Raghavan, who had previously announced his mid-January 2023 retirement, following a longstanding and impactful career with Atrium Health, and by Dr. William Blackstock, professor and chair of radiation oncology at Wake Forest University School of Medicine, who has served as interim director of Wake Derek Raghavan, M.D., Ph.D., President of the Levine Cancer Institute, has been appointed Vice Chairman of the Network to help guide the development of standards for tumor profiling and research protocols integrating tumor profiling. Additionally, Edward Kim, M.D., Department Chair of Solid Tumor Oncology at Levine Cancer Institute, will also |evq| dgw| sbe| ktr| yne| oes| tsq| nxo| gnp| tbi| nwp| nix| rbu| ewk| ybx| nqd| jpo| emp| ged| ofj| bst| xso| vue| whk| kvv| gfm| vyl| jcr| ylx| hau| ziu| sij| eyw| njg| cfm| eqo| cxs| iat| mff| cri| oeu| mni| nil| ttb| ikf| qba| gnx| grc| mot| dep|